Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Narrative (Details)

v3.23.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2023
Jun. 30, 2021
Jun. 30, 2022
Revenue Recognition        
Proceeds from non-Medicare laboratory services   $ 0.9    
Proceeds from Laboratory Services Reimbursed by Medicare     $ 0.5  
Contract with Customer, Liability, Total $ 26.5 26.5   $ 25.5
Contract with Customer, Liability, Revenue Recognized $ 3.6 $ 19.5